Prosthetic Heart Valve Devices And Equipment Market Projected To Surpass $10.48 Billion By 2030 At 9.9% CAGR
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Prosthetic Heart Valve Devices And Equipment Market?
The market size for prosthetic heart valve devices and equipment has experienced robust growth in recent years. This market is projected to expand from $6.73 billion in 2025 to $7.17 billion in 2026, at a compound annual growth rate (CAGR) of 6.5%. The growth observed in prior periods can be attributed to the increasing prevalence of valvular heart diseases, a rising aging population, the expansion of cardiac surgery programs, the growing adoption of valve replacement procedures, and advancements in cardiac imaging technologies.
The market for prosthetic heart valve devices and equipment is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $10.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This projected growth is driven by several factors, including a greater preference for minimally invasive cardiac procedures, an escalating need for durable valve implants, the broadening of transcatheter valve applications, increasing financial commitments to treating structural heart diseases, and advancements in biological valve materials. Key trends anticipated during this period encompass a rise in the use of transcatheter heart valve procedures, a heightened demand for tissue-based heart valves, an expanded application of minimally invasive valve repair systems, the development of advanced valve durability technologies, and a stronger emphasis on customized patient valve solutions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2416&type=smp
Which Core Factors Are Supporting The Expansion Of The Prosthetic Heart Valve Devices And Equipment Market?
The increasing incidence of valvular heart disease has spurred a demand for transcatheter aortic valve replacement (TAVR) procedures, thereby boosting the prosthetic heart valve devices and equipment market. TAVR is a less invasive surgical procedure performed to treat aortic stenosis, a type of valvular heart disease impacting the heart’s aortic valve. Aortic stenosis hardens the aortic valve, impeding proper blood flow, and TAVR effectively replaces this impaired valve with a transcatheter one. For example, data from May 2023, provided by the Centers for Disease Control and Prevention, a US-based government agency, indicated that more than 695,000 people in the US succumbed to heart disease, representing one out of every five deaths. With the increasing rate of valvular heart disease cases, the volume of TAVR procedures is projected to grow, consequently elevating the demand for transcatheter valves and propelling the market in the future.
Which Segment Groups Define The Prosthetic Heart Valve Devices And Equipment Market Landscape?
The prosthetic heart valve devices and equipment market covered in this report is segmented –
1) By Product Type: Repair Products, Mitral Valve Repair Devices, Tricuspid Valve Repair Devices
2) By Valve Type: Transcatheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve
3) By Technology: Biological Valve, Decellularized Valve
4) By Application: Hospitals, Ambulatory Surgery Centres
Subsegments:
1) By Repair Products: Transcatheter Mitral Valve Repair (TMVR) Devices, Transcatheter Tricuspid Valve Repair (TTVR) Devices
2) By Mitral Valve Repair Devices: Mitral Valve Repair Systems (MitraClip), Mitral Valve Annuloplasty Devices, Edge-to-Edge Repair Devices
3) By Tricuspid Valve Repair Devices: Tricuspid Valve Annuloplasty Devices, Tricuspid Valve Repair Systems
What Trends Are Shaping The Prosthetic Heart Valve Devices And Equipment Market Structure?
Major companies within the prosthetic heart valve devices and equipment market are actively developing tricuspid valve replacement systems. This development aims to satisfy the increasing need for effective treatments for tricuspid valve disease, enhance patient outcomes, and mitigate complications associated with traditional heart valve surgeries. Tricuspid valve replacement systems are defined as medical apparatuses designed to replace the tricuspid valve in the heart, which is responsible for regulating blood flow between the right atrium and right ventricle. For instance, in October 2023, Edwards Lifesciences, a US-based technology company, obtained CE Mark approval for its EVOQUE system, marking it as the world’s first transcatheter valve replacement therapy sanctioned for treating tricuspid regurgitation (TR). The EVOQUE valve incorporates a nitinol self-expanding frame and tissue leaflets constructed from bovine pericardial tissue. It is engineered for delivery through a low-profile transfemoral 28-French system and will be offered in three sizes.
Who Are The Companies Shaping The Prosthetic Heart Valve Devices And Equipment Market Landscape?
Major companies operating in the prosthetic heart valve devices and equipment market are Boston Scientific Corporation, Edwards Lifesciences, Medtronic plc, LivaNova plc, Abbott Laboratories, Jenavalve Technology Inc., Lepu Medical Technology, Cryolife Inc., Neovasc Inc., Braile Biomedica, Colibri Heart Valve, TTK Healthcare Ltd., Medical Technology Est., Micro Interventional Devices Inc., Well Health Technologies, On-X Life Technologies Inc., Meril Life Sciences Pvt. Ltd., Sorin Group, Commonwealth Edison Company, Cardiac Dimensions Inc., CardioSolutions Inc., Leman Cardiovascular, MitralSolutions Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Xeltis AG, Transcatheter Technologies GmbH, Venus Medtech (Hangzhou) Inc., MValve Technologies Ltd., MVRx Inc., NaviGate Cardiac Structures Inc., Pulmonx Corporation, Tendyne Holdings Inc., ValveXchange Inc., Vascutek Ltd., XpandOrtho Inc., Zhejiang A&F Medical Co. Ltd.
Access The Complete Prosthetic Heart Valve Devices And Equipment Market Report:
Which Region Has The Strongest Presence In The Prosthetic Heart Valve Devices And Equipment Market?
North America was the largest region in global prosthetic heart valve devices and equipment market in 2025. Western Europe was the second-largest region in prosthetic heart valve devices and equipment market. The regions covered in the prosthetic heart valve devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Prosthetic Heart Valve Devices And Equipment Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Prosthetic Heart Valve Devices And Equipment Market 2026, By The Business Research Company
Cardiac Prosthetic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-prosthetic-devices-global-market-report
Cardiovascular Surgery Devices And Equipment Market Report 2026
Heart Pump Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-pump-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
